Venk Murthy MD PhD(@venkmurthy) 's Twitter Profileg
Venk Murthy MD PhD

@venkmurthy

#cardiometabolic #prevention; Multimodality #cvimaging; Posts may be my opinions & are not medical advice; RT≠endorse

ID:25029854

linkhttps://scholar.google.com/citations?user=nNET6osAAAAJ calendar_today18-03-2009 04:47:46

57,0K Tweets

22,0K Followers

2,0K Following

Venk Murthy MD PhD(@venkmurthy) 's Twitter Profile Photo

Not so simple IMO!

* Potential adverse effects on finances & well-being

* PRS modest discrimination for CVD, BP, lipids, BMI, T2D beyond standard clinical data

* Many PRS scores for each & agreement isn't great. Many folks will be in top 5-10% of 1 score but not another

Even…

account_circle
Richard Ferraro(@RichardAFerraro) 's Twitter Profile Photo

Results for STEP-HFpEF DM Trial

Baseline medication use in the trial. Why are OVER 80% of pts with HFpEF on beta blocker when we know this worsens symptoms?

Results for #ACC24 STEP-HFpEF DM Trial Baseline medication use in the trial. Why are OVER 80% of pts with HFpEF on beta blocker when we know this worsens symptoms?
account_circle
Veera Rajagopal (@doctorveera) 's Twitter Profile Photo

In a new paper in Nature Genetics, scientists from MRC Epidemiology Unity, University of Cambridge, report a new obesity gene--BSN (nature.com/articles/s4158…). Loss of function mutation in BSN causes an extreme form of obesity that is reminiscent of the weight gain associated with…

In a new paper in @NatureGenet, scientists from MRC Epidemiology Unity, University of Cambridge, report a new obesity gene--BSN (nature.com/articles/s4158…). Loss of function mutation in BSN causes an extreme form of obesity that is reminiscent of the weight gain associated with…
account_circle
NimwegenLab(@NimwegenLab) 's Twitter Profile Photo

No, tSNE/UMAP don't 'preserve neighborhoods'.
Fig 2d shows that tSNE and UMAP get the large majority of k nearest neighbors wrong on all datasets. And this is 'recall' not even of true cell positions but just the logp1 mappings of the raw data!

account_circle
Venk Murthy MD PhD(@venkmurthy) 's Twitter Profile Photo

Back in Nov 2023, safety concerns led me to suggest stopping trials of $VERV's VERVE-101 gene therapy for PCSK9.

Today the company did so.

account_circle
Venk Murthy MD PhD(@venkmurthy) 's Twitter Profile Photo

Good decision!

Even better to start with rare diseases for which there are no other treatments rather than diseases where there are several safe monthly or twice years meds with similar efficacy.

My thoughts here from a few months back:

venkmurthy.substack.com/p/editing-the-…

account_circle
Venk Murthy MD PhD(@venkmurthy) 's Twitter Profile Photo

Important study by Krishna Patel and colleagues in Journal of Nuclear Cardiology: Balanced ischemia is rarely missed with stress PET.

Much of prior literature on this influenced by SPECT without attenuation correction, which unfortunately is still frequently used.

PET MPI is even better with…

account_circle
Venk Murthy MD PhD(@venkmurthy) 's Twitter Profile Photo

I'm always hesitant to use use terms like game changer, but these are the three trials that could have the greatest impact on practice of cardiology, depending on results. Nice summary by John Mandrola, MD

sensible-med.com/p/modern-cardi…

account_circle
ASNC Society(@MyASNC) 's Twitter Profile Photo

49-year-old with frequent VEs underwent rest Rb-82 imaging and 24-hr. carbohydrate-restricted diet for F-18 FDG PET to exclude cardiac sarcoidosis. Beta-hydroxybutyrate level < 0.2 mmol/L (normal > 0.3 mmol/L). What is your interpretation? Vote below.

49-year-old with frequent VEs underwent rest Rb-82 imaging and 24-hr. carbohydrate-restricted diet for F-18 FDG PET to exclude cardiac sarcoidosis. Beta-hydroxybutyrate level < 0.2 mmol/L (normal > 0.3 mmol/L). What is your interpretation? Vote below.
account_circle